Morgan Stanley Intercure Ltd. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Intercure Ltd. stock. As of the latest transaction made, Morgan Stanley holds 4,000 shares of INCR stock, worth $4,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$4,680
Previous $8,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INCR
# of Institutions
25Shares Held
3.44MCall Options Held
19.5KPut Options Held
100-
Ibex Investors LLC1.89MShares$2.21 Million9.38% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$949,2010.06% of portfolio
-
Toroso Investments, LLC Massapequa, NY230KShares$268,5150.01% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$248,6240.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD107KShares$125,6740.04% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $52.8M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...